translational medicine | KCUR

translational medicine

user Mrd7b2 / Wikipedia

On November 5, Jackson County voters will decide whether to fund a translational medicine institute. A proposed half-cent sales tax would raise $800 million over the next 20 years to be divided among Children’s Mercy Hospital, St. Luke’s Hospital and the University of Missouri-Kansas City School of Medicine.

Ten percent of the $800 million and 20 percent of profits the program generates would fund local public health initiatives.


Jackson County voters head to the polls on November 5 to vote on a 1/2 cent sales tax increase to fund a translational medicine institute. 

In the first part of Tuesday's Up to Date, a proponent and opponent of the tax meet in our studios to debate the controversial proposal, including how county residents will actually benefit from the project.


Children's Mercy Hospital

On Wednesday, the Hall Family Foundation announced that it was pledging $75 million to Children's Mercy Hospital for build a translational medicine research building on Children's Mercy's campus on Hospital Hill.

Wikipedia Commons

The Hall Family Foundation is pledging $75 million to build a research building at Children’s Mercy Hospital, but only if Jackson County voters pass a half-cent medical research sales tax. 

At the hospital Wednesday, foundation president Bill Hall said the tax offers Kansas City a big opportunity.

"We recognize it is asking a great deal of the voters of Jackson County," he said. "However, we believe this is a moment we must seize. The tax is transformational."

Wikipedia Commons

The Jackson County Legislature voted Monday to place a 20-year, half-cent sales tax measure on the November 5 ballot.

Aimed at boosting economic development and funding research, supporters call it a game-changer for Kansas City, a way to bolster the area's claim as a hub of life science research. Opponents haven't galvanized, at least in a visible way. But lots of questions are being raised.

user Mrd7b2 / Wikipedia

Researchers in Kansas City may have developed a way to speed up the diagnosis of critically ill infants with genetic diseases.